Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Gainesville, Florida 32611


Purpose:

This is a multicenter, prospective single-arm trial evaluating the safety and efficacy of the Axium MicroFX coil system in 100 aneurysms.


Study summary:

This is a multicenter, prospective single-arm trial evaluating the safety and efficacy of the Axium MicroFX coil system in 99 patients at 13 study centers. The primary endpoint of the trial was the anatomic occlusion of the aneurysm in the immediate post-procedure angiogram basedon the Raymond classification. Secondary endpoints included safety during the procedure, safety after the procedure, detachment system performance, stability of the embolization, and packing efficacy.


Criteria:

Inclusion Criteria: - Confirmed diagnosis of one or more intracranial aneurysm, either ruptured or unruptured. - Information on data collection provided to the patient or legally authorized representative and signed informed consent. - Aneurysm diameter ≤10mm . - Age range of 18 - 90. Exclusion Criteria: - Aneurysm previously treated. - Aneurysm AVM related or dissecting. - Participation in a clinical investigation of other aneurysm treating or related devices. - Any condition that would preclude the conduct of protocol follow-up. - Aneurysm anatomy that is determined inappropriate for Axium coil placement, prior to opening of an Axium coil.


NCT ID:

NCT01323439


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Gainesville, Florida 32611
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.